Brian Østergaard

583 total citations
21 papers, 424 citations indexed

About

Brian Østergaard is a scholar working on Oncology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Brian Østergaard has authored 21 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Hematology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Brian Østergaard's work include Multiple Myeloma Research and Treatments (14 papers), Cancer Treatment and Pharmacology (8 papers) and Bone health and treatments (7 papers). Brian Østergaard is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Cancer Treatment and Pharmacology (8 papers) and Bone health and treatments (7 papers). Brian Østergaard collaborates with scholars based in United States, Denmark and Norway. Brian Østergaard's co-authors include Niels Abildgaard, David J. Collins, Martin Kaiser, Jon Thor Asmussen, Matthew Blackledge, Stefan Delorme, Heinz-Peter Schlemmer, Christina Messiou, Jens Hillengaß and Anwar R. Padhani and has published in prestigious journals such as Radiology, European Journal of Nuclear Medicine and Molecular Imaging and European Journal Of Haematology.

In The Last Decade

Brian Østergaard

20 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Østergaard United States	9	244	159	137	115	56	21	424
Kyoko Haraguchi Japan	9	132 0.5×	99 0.6×	69 0.5×	116 1.0×	25 0.4×	27	457
Silvia Buttignol Italy	5	657 2.7×	392 2.5×	301 2.2×	70 0.6×	35 0.6×	8	716
Konstantinos Tsionos Greece	11	317 1.3×	434 2.7×	207 1.5×	50 0.4×	56 1.0×	22	630
Pauline Beaussart France	11	73 0.3×	139 0.9×	29 0.2×	219 1.9×	41 0.7×	13	501
Liza Robles‐Carrillo United States	10	100 0.4×	91 0.6×	89 0.6×	92 0.8×	29 0.5×	18	394
D. S. Verma United States	9	265 1.1×	182 1.1×	82 0.6×	26 0.2×	44 0.8×	13	450
Chongjiao Li China	12	42 0.2×	190 1.2×	65 0.5×	168 1.5×	42 0.8×	34	368
Sosana Delimpasi Greece	12	509 2.1×	364 2.3×	399 2.9×	36 0.3×	26 0.5×	61	649
P. Dunn United Kingdom	6	171 0.7×	93 0.6×	66 0.5×	33 0.3×	23 0.4×	6	314
Violaine Safar France	10	96 0.4×	184 1.2×	78 0.6×	127 1.1×	94 1.7×	24	529

Countries citing papers authored by Brian Østergaard

Since Specialization

Citations

This map shows the geographic impact of Brian Østergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Østergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Østergaard more than expected).

Fields of papers citing papers by Brian Østergaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Østergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Østergaard. The network helps show where Brian Østergaard may publish in the future.

Co-authorship network of co-authors of Brian Østergaard

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Østergaard. A scholar is included among the top collaborators of Brian Østergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Østergaard. Brian Østergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zadeh, Mahdi Zirakchian, Brian Østergaard, William Raynor, et al.. (2020). Comparison of 18F-sodium fluoride uptake in the whole bone, pelvis, and femoral neck of multiple myeloma patients before and after high-dose therapy and conventional-dose chemotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 47(12). 2846–2855. 15 indexed citations

Zadeh, Mahdi Zirakchian, Siavash Mehdizadeh Seraj, Brian Østergaard, et al.. (2020). Prognostic significance of ¹⁸F-sodium fluoride in newly diagnosed multiple myeloma patients.. PubMed. 10(4). 151–160. 14 indexed citations

Zadeh, Mahdi Zirakchian, William Raynor, Brian Østergaard, et al.. (2020). Correlation of whole-bone marrow dual-time-point ¹⁸F-FDG, as measured by a CT-based method of PET/CT quantification, with response to treatment in newly diagnosed multiple myeloma patients.. PubMed. 10(5). 257–264. 8 indexed citations

Zadeh, Mahdi Zirakchian, Brian Østergaard, William Raynor, et al.. (2020). Correlation between whole-bone marrow 18F-FDG uptake and prognostic factors in newly diagnosed multiple myeloma patients. University of Southern Denmark Research Portal (University of Southern Denmark). 61. 99–99. 1 indexed citations

Shamchi, Sara Pourhassan, Mahdi Zirakchian Zadeh, Brian Østergaard, et al.. (2020). Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation. Nuclear Medicine Communications. 41(3). 288–293. 5 indexed citations

Messiou, Christina, Jens Hillengaß, Stefan Delorme, et al.. (2019). Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS). Radiology. 291(1). 5–13. 218 indexed citations

Zadeh, Mahdi Zirakchian, Brian Østergaard, Cyrus Ayubcha, et al.. (2019). Baseline global splenic uptake of FDG in multiple myeloma patients: a higher uptake is associated with inferior overall survival. University of Southern Denmark Research Portal (University of Southern Denmark). 60. 22–22. 1 indexed citations

Seraj, Siavash Mehdizadeh, Abdullah Al-Zaghal, Brian Østergaard, Poul Flemming Høilund‐Carlsen, & Abass Alavi. (2019). Identification of Heterotopic Ossification Using 18F-NaF PET/CT. Clinical Nuclear Medicine. 44(4). 319–320. 8 indexed citations

Zadeh, Mahdi Zirakchian, William Raynor, Brian Østergaard, et al.. (2018). Changes in bone marrow FDG uptake in multiple myeloma patients before and after treatment. University of Southern Denmark Research Portal (University of Southern Denmark). 58(1). 5 indexed citations

10.

Zadeh, Mahdi Zirakchian, William Raynor, Brian Østergaard, et al.. (2018). Assessment of bone turnover in multiple myeloma patients before and after treatment. University of Southern Denmark Research Portal (University of Southern Denmark). 59. 1 indexed citations

11.

Preiss, Birgitte, Per Trøllund Pedersen, Brian Østergaard, et al.. (2018). Myc protein overexpression is a feature of progression and adverse prognosis in multiple myeloma. European Journal Of Haematology. 101(5). 585–590. 13 indexed citations

12.

Raynor, William, Brian Østergaard, Mahdi Zirakchian Zadeh, et al.. (2017). Global quantification of NaF in the skeleton: assessing bone formation in multiple myeloma patients before and after treatment. University of Southern Denmark Research Portal (University of Southern Denmark). 58(1). 1 indexed citations

13.

Zadeh, Mahdi Zirakchian, Brian Østergaard, William Raynor, et al.. (2017). Comparison of global uptake of NaF-PET/CT in whole-body bone in multiple myeloma and healthy controls. University of Southern Denmark Research Portal (University of Southern Denmark). 58. 1 indexed citations

14.

Østergaard, Brian, Mahdi Zirakchian Zadeh, William Raynor, et al.. (2017). Correlation of Dual Time Point FDG-PET with Response to Chemotherapy in Multiple Myeloma. University of Southern Denmark Research Portal (University of Southern Denmark). 58. 188. 6 indexed citations

15.

Raynor, William, Brian Østergaard, Mahdi Zirakchian Zadeh, et al.. (2017). Feasibility of using global FDG uptake in bone marrow to assess treatment of multiple myeloma. University of Southern Denmark Research Portal (University of Southern Denmark). 58. 2 indexed citations

16.

Zadeh, Mahdi Zirakchian, Brian Østergaard, William Raynor, et al.. (2017). Quantification of the total bone marrow activity with FDG-PET in multiple myeloma before and after treatment: comparison with a control group. University of Southern Denmark Research Portal (University of Southern Denmark). 58(1). 3 indexed citations

17.

Sørrig, Rasmus, Tobias Wirenfeldt Klausen, Morten Salomo, et al.. (2015). Smoldering multiple myeloma risk factors for progression: a Danish population‐based cohort study. European Journal Of Haematology. 97(3). 303–309. 45 indexed citations

18.

Nahi, Hareth, Thea Kristin Våtsveen, Johan Lund, et al.. (2015). Proteasome inhibitors and IMiDs can overcome some high‐risk cytogenetics in multiple myeloma but not gain 1q21. European Journal Of Haematology. 96(1). 46–54. 31 indexed citations

19.

Søndergaard, Teis Esben, Kent Søe, Thomas Lund, et al.. (2008). A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma. Hematological Oncology. 27(1). 17–22. 45 indexed citations

20.

Østergaard, Brian, et al.. (1985). [Cimetidine-induced climacteric symptoms in a perimenopausal woman].. PubMed. 147(46). 3702–3.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact